Stason Pharmaceuticals, Inc. recalls Mercaptopurine Tablets, USP 50 mg, packaged in: a) 25-count bottle (NDC 69076-913-02), b) 250-count bottle (NDC 69076-91
Recalled March 13, 2024 · FDA recall D-0367-2024 · Stason Pharmaceuticals
Hazard
Failed Dissolution Specifications: results slightly under spec at at 9-months. · FDA Class III
Units
54, 131 bottles
Sold at
USA Nationwide
Description
Failed Dissolution Specifications: results slightly under spec at at 9-months.
Product
Mercaptopurine Tablets, USP 50 mg, packaged in: a) 25-count bottle (NDC 69076-913-02), b) 250-count bottle (NDC 69076-913-25), Rx only, Manufactured for: Quinn Pharmaceuticals, Boca Raton, FL, www.quinnrx.com
Manufacturer(s)
Stason Pharmaceuticals, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →